Currently out of the existing stock ratings of Chris Cooley, 79 are a BUY (80.61%), 19 are a HOLD (19.39%).

Chris Cooley

Work Performance Price Targets & Ratings Chart

Analyst Chris Cooley, currently employed at STEPHENS, carries an average stock price target met ratio of 65.71% that have a potential upside of 34.87% achieved within 287 days.

Chris Cooley’s has documented 200 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VCEL, Vericel Corp Ord at 11-May-2023.

Wall Street Analyst Chris Cooley

Analyst best performing recommendations are on SDC (SMILEDIRECTCLUB).
The best stock recommendation documented was for SDC (SMILEDIRECTCLUB) at 8/10/2022. The price target of $2 was fulfilled within 5 days with a profit of $0.7 (53.85%) receiving and performance score of 107.69.

Average potential price target upside

of $48.95 (16.89%) on ALGN (ALIGN TECHNOLOGY).
of $31.04 (15.77%) on TFX (TELEFLEX).
of $29.25 (16.15%) on ABMD (ABIOMED).

ALC Alcon AG ALGN Align Technology AVNS Avanos Medical COO The Cooper Companies Common Stock DXCM DexCom GKOS Glaukos Corp PLSE Pulse Biosciences SDC SmileDirectClub SIEN Sientra STE STERIS plc TFX Teleflex VCEL Vericel Corp Ord ABMD ABIOMED APEN Apollo Endosurgery BSX Boston Scientific Corp ESTA Establishment Labs Holdings ANIK Anika Therapeutics STAA STAAR Surgical Company CUTR Cutera XRAY Dentsply Sirona ELGX Endologix

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score